biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 223 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Mr. Bret Christensen es el Chief Executive Officer de Biote Corp, se unió a la empresa desde 2025.
¿Qué tal es el rendimiento del precio de la acción BTMD?
El precio actual de BTMD es de $2.21, ha 下降 un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Biote Corp?
Biote Corp pertenece a la industria Pharmaceuticals y el sector es Health Care
¿Cuál es la capitalización bursátil de Biote Corp?
La capitalización bursátil actual de Biote Corp es $86.8M
¿Es Biote Corp una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 7 analistas han realizado calificaciones de análisis para Biote Corp, incluyendo 3 fuerte compra, 6 compra, 2 mantener, 0 venta, y 3 fuerte venta